GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1876 - 1900** of **4050** in total

« First

‹ Prev

…

72

73

74

75

76

77

78

79

80

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgA	Patient 2	3	mild	G39023AU	314
IgG	Patient 2	3	mild	G39023AU	45
IgM	Patient 2	3	mild	G39023AU	169
IgA	Patient 3	-180	mild	G39023AU	288
IgA	Patient 3	11	mild	G39023AU	418
IgG	Patient 3	-180	mild	G39023AU	64
IgM	Patient 3	-180	mild	G39023AU	220
IgA	Patient 3	4	mild	G39023AU	455
IgG	Patient 3	11	mild	G39023AU	77
IgG	Patient 3	4	mild	G39023AU	77
IgM	Patient 3	11	mild	G39023AU	273
IgM	Patient 3	4	mild	G39023AU	325
IgA	Patient 4	12	mild	G39023AU	423
IgG	Patient 4	12	mild	G39023AU	122
IgM	Patient 4	12	mild	G39023AU	468
IgA	Patient 1	10	moderate	G39213VZ	361
IgA	Patient 1	22	moderate	G39213VZ	371
IgA	Patient 1	6	moderate	G39213VZ	323
IgG	Patient 1	10	moderate	G39213VZ	24
IgG	Patient 1	22	moderate	G39213VZ	31
IgM	Patient 1	10	moderate	G39213VZ	33
IgM	Patient 1	22	moderate	G39213VZ	116
IgA	Patient 2	15	mild	G39213VZ	586
IgA	Patient 2	24	mild	G39213VZ	665
IgG	Patient 2	15	mild	G39213VZ	47